Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burkhardt Dahlmann

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Neurochemistry|February 9, 2007
The 20S proteasome isolated from Alzheimer's disease brain shows post-translational modifications but unchanged proteolytic activityFrank Gillardon, Alexander Kloss, Matthias Berg, et al.
Journal of Cellular and Molecular Medicine|December 6, 2013
T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomesIsabel Bochmann, Frédéric Ebstein, Andrea Lehmann, et al.
Annals of Hepatology|June 14, 2014
Adult human liver contains intermediate-type proteasomes with different enzymatic propertiesSabrina Gohlke, Alexander Kloss, Michael Tsokos, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 26, 2008
The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activitiesAlexander Kloss, Peter Henklein, Dagmar Siele, et al.
Proteomics|July 22, 2006
Comprehensive quantitative proteome analysis of 20S proteasome subtypes from rat liver by isotope coded affinity tag and 2-D gel-based approachesFrank Schmidt, Burkhardt Dahlmann, Katharina Janek, et al.
Gynecologic Oncology|November 16, 2010
The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancerMartin Heubner, Pauline Wimberger, Burkhardt Dahlmann, et al.
Plos One|May 14, 2013
Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brainCarolin Giannini, Alexander Kloß, Sabrina Gohlke, et al.
Nature Structural & Molecular Biology|January 27, 2009
Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasomeDawadschargal Bech-Otschir, Annett Helfrich, Cordula Enenkel, et al.
Anticancer Research|July 9, 2011
Circulating 20S proteasome in patients with non-metastasized breast cancerOliver Hoffmann, Martin Heubner, Timur Anlasik, et al.
Amino Acids|April 6, 2010
Quantitative proteome analysis of the 20S proteasome of apoptotic Jurkat T cellsFrank Schmidt, Burkhardt Dahlmann, Hanne K Hustoft, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Neurochemistry|February 9, 2007
The 20S proteasome isolated from Alzheimer's disease brain shows post-translational modifications but unchanged proteolytic activityFrank Gillardon, Alexander Kloss, Matthias Berg, et al.
Journal of Cellular and Molecular Medicine|December 6, 2013
T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomesIsabel Bochmann, Frédéric Ebstein, Andrea Lehmann, et al.
Annals of Hepatology|June 14, 2014
Adult human liver contains intermediate-type proteasomes with different enzymatic propertiesSabrina Gohlke, Alexander Kloss, Michael Tsokos, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 26, 2008
The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activitiesAlexander Kloss, Peter Henklein, Dagmar Siele, et al.
Proteomics|July 22, 2006
Comprehensive quantitative proteome analysis of 20S proteasome subtypes from rat liver by isotope coded affinity tag and 2-D gel-based approachesFrank Schmidt, Burkhardt Dahlmann, Katharina Janek, et al.
Gynecologic Oncology|November 16, 2010
The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancerMartin Heubner, Pauline Wimberger, Burkhardt Dahlmann, et al.
Plos One|May 14, 2013
Poly-Ub-substrate-degradative activity of 26S proteasome is not impaired in the aging rat brainCarolin Giannini, Alexander Kloß, Sabrina Gohlke, et al.
Nature Structural & Molecular Biology|January 27, 2009
Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasomeDawadschargal Bech-Otschir, Annett Helfrich, Cordula Enenkel, et al.
Anticancer Research|July 9, 2011
Circulating 20S proteasome in patients with non-metastasized breast cancerOliver Hoffmann, Martin Heubner, Timur Anlasik, et al.
Amino Acids|April 6, 2010
Quantitative proteome analysis of the 20S proteasome of apoptotic Jurkat T cellsFrank Schmidt, Burkhardt Dahlmann, Hanne K Hustoft, et al.
Pageof 3